Gene editing for HSV-1 shows significant reduction of viral load
The experimental therapy eliminated 90 percent of HSV-1 after facial infection and 97 percent of HSV-1 after genital infection.
List view / Grid view
The experimental therapy eliminated 90 percent of HSV-1 after facial infection and 97 percent of HSV-1 after genital infection.
Researchers uncover a genetic pathway of parietal cell development, which will enable a better understanding of stomach conditions.
Heightened insulin resistance in obese men may elucidate the higher prevalence of type 2 diabetes among these individuals.
The new study provides proof of principle that functional liver cells can be grown in a different species, offering a potential solution to transplant shortage.
The discovery that omental fat has a mechanism to limit adipocyte formation may lead to new treatments for obesity and metabolic disease.
Through in vitro and in vivo models, researchers find a mechanism by which bacteria-generated fatty acids regulate immune responses.
The screening model combines maternal history, ultrasound data and several tests for blood markers to enable personalised treatment.
A specialised drug-loaded nanoparticle, which can cross the blood-brain barrier, shrunk both breast tumours and breast cancer cells.
Patients with no detectable FLT3 mutations had the best outcomes after an allogenic hematopoietic cell transplant.
Researchers showed that ESI1, or similar compounds, may help to slow or even reverse cognitive losses that can occur during aging.
Researchers found that genetic depletion of cyclophilin A results in stem cells distinctively lacking intrinsically disordered proteins.
Scientists have discovered that each rheumatoid arthritis patient possesses a unique and diverse set of ACPAs.
Induced NPCs facilitate the creation of patient-specific organoid models and improve identification of nephron targeted drugs.
Researchers discovered that measuring the concentrations of IL-18 in an individual’s blood could estimate future risk of stroke.
Confounder control and quantitative profiling revealed misleading associations between microbial markers and colorectal cancer development.